Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Multiple Myeloma 8Leukemia 6Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Burkitt Lymphoma 3Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Lymphoma 2Leukemia, T-Cell 2Waldenstrom Macroglobulinemia 1Vomiting 1Uterine Cervical Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Mouth Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Fatigue 1Congenital Abnormalities 1Breast Neoplasms 1Breast Carcinoma In Situ 1Brain Neoplasms 1

Interventions

Methylphenidate 3Melatonin 2dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Ultraviolet Therapy 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sildenafil Citrate 1Radiotherapy 1Dexamethasone 1Darbepoetin alfa 1Consolidation Chemotherapy 1Cognitive Behavioral Therapy 1Chemoradiotherapy 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Fatigue × Dexamethasone × Clear all
NCT02491632 2026-03-18

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Active not recruiting
90 enrolled 13 charts

Fatigue, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡